Pain News and Research

Latest Pain News and Research

VHI publishes hospital patient satisfaction information on website

Virginia Health Information (VHI) has published hospital patient satisfaction information on their website.

15 May 2014

Eleven Biotherapeutics reports financial results and operational highlights for Q1 2014

Eleven Biotherapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today reported financial results and operational highlights for the quarter ended March 31, 2014.

15 May 2014

In-office treatment using balloon sinus dilation is as effective as FESS for chronic sinusitis

New results from a randomized trial published in the American Journal of Rhinology and Allergy demonstrate the benefits of in-office balloon dilation for sufferers of chronic sinusitis.

15 May 2014

Prestige Brands’ net revenues decrease $144.3M to 6.6% in Q4 and FY 2014

Prestige Brands Holdings, Inc. ("the Company") today announced results for the fourth quarter and the fiscal year ended March 31, 2014.

15 May 2014

Depression is the leading cause of illness in adolescents, shows WHO's report

WHO's "Health for the world's adolescents" report reveals that depression is the predominant cause of illness and disability for both boys and girls aged 10 to 19 years.

15 May 2014

Sorrento Therapeutics prices underwritten public offering of 4,765,000 shares of common stock

Sorrento Therapeutics, Inc. ("Sorrento" or the "Company"), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced the pricing of an underwritten public offering of 4,765,000 shares of common stock at a public offering price of $5.25 per share.

15 May 2014

Novel targeted drug shows promise in treating patients with advanced pigmented villonodular synovitis

A novel targeted drug shows promise in treating patients with advanced pigmented villonodular synovitis (PVNS), a rare neoplastic joint disorder, according to new phase I data from Memorial Sloan Kettering Cancer Center and other institutions highlighted to media today in advance of the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO), which will take place from May 30 to June 3 in Chicago.

15 May 2014

Phase I study reveals abemaciclib drug shows evidence of single-agent activity in NSCLC patients

Abemaciclib, an oral drug administered twice daily, currently in development by Eli Lilly and Company (NYSE: LLY), has shown evidence of single-agent activity in patients with advanced non-small cell lung cancer in a Phase I study released ahead of the American Society of Clinical Oncology (ASCO) Annual Meeting to be held in Chicago, Ill.

15 May 2014

Researchers show how cone snails venom inhibits neuronal calcium channels to reduce neuropathic pain

The venom from marine cone snails, used to immobilize prey, contains numerous peptides called conotoxins, some of which can act as painkillers in mammals. A recent study in The Journal of General Physiology provides new insight into the mechanisms by which one conotoxin, Vc1.1, inhibits pain.

15 May 2014

Two new Manchester research centres aim at improving lives of people with arthritis

Two major new research centres at The University of Manchester aimed at improving the lives of people with arthritis are to be officially launched on May 19.

14 May 2014

Tips to prevent sunburn and reduce risk of skin cancer

While warmer weather means more outdoor activities, it also means carefully protecting your skin from the sun.

14 May 2014

UNF Professor discovers 2 Lyme disease bacterial species that infect human patients

Dr. Kerry Clark, associate professor of public health at the University of North Florida in Jacksonville, and his colleagues have found additional cases of Lyme disease in patients from several states in the southeastern U.S. These cases include two additional Lyme disease Borrelia species recently identified in patients in Florida and Georgia.

14 May 2014

Infosys wins 2014 Simulating Reality contest for innovation in osteoporosis diagnosis

Infosys, a global leader in technology, consulting and outsourcing solutions, has been recognized as a winner in the 2014 Simulating Reality contest. The contest is organized by MSC Software, a worldwide leader of multidisciplinary simulation solutions.

13 May 2014

Medicare roundup: Alabama pain clinic spending 'hotspot'; quality improvement program scrutinized

Also, the controversy about paying for a hepatitis-C cure and reinstating physicians who lost their licenses.

13 May 2014

Bullied children may experience long term health problems

Bullied children may experience chronic, systemic inflammation that persists into adulthood, while bullies may actually reap health benefits of increasing their social status through bullying, according to researchers at Duke Medicine.

13 May 2014

Delayed care for Veterans is a hot topic on Sunday news shows, in headlines

Secretary of Defense Chuck Hagel said what is now a scandal should have been ex amined years ago. Meanwhile, USA Today and the Arizona Republic have more tales of delayed care.

13 May 2014

Neuropathic pain features common in knee OA

Enough patients with knee osteoarthritis experience pain with neuropathic characteristics to warrant attempts to diagnose and classify these features, say researchers.

12 May 2014

PhotoMedex revenues decrease 12% to $50.1 million in first quarter 2014

PhotoMedex, Inc. reports financial results for the three months ended March 31, 2014 and announces LCA-Vision stockholder approval of PhotoMedex's previously announced acquisition of all outstanding shares of LCA-Vision, a leading provider of laser vision correction services under the LasikPlus brand.

12 May 2014

NPS MedicineWise welcomes ABC’s decision to take down Catalyst program on statins, heart disease

NPS MedicineWise has welcomed the ABC’s ruling — published today — that its Catalyst program aired in October 2013 on statins and heart disease breached its own standards on impartiality.

12 May 2014

Aratana initiates pivotal field effectiveness study for AT-001

Aratana Therapeutics, Inc., a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for cats, dogs and other companion animals, today announced the initiation of the pivotal field effectiveness study for AT-001 (grapiprant), the company's innovative drug for treating pain in dogs with osteoarthritis.

12 May 2014

Pain News and Research

Latest Pain News and Research

VHI publishes hospital patient satisfaction information on website

Eleven Biotherapeutics reports financial results and operational highlights for Q1 2014

In-office treatment using balloon sinus dilation is as effective as FESS for chronic sinusitis

Prestige Brands’ net revenues decrease $144.3M to 6.6% in Q4 and FY 2014

Depression is the leading cause of illness in adolescents, shows WHO's report

Sorrento Therapeutics prices underwritten public offering of 4,765,000 shares of common stock

Novel targeted drug shows promise in treating patients with advanced pigmented villonodular synovitis

Phase I study reveals abemaciclib drug shows evidence of single-agent activity in NSCLC patients

Researchers show how cone snails venom inhibits neuronal calcium channels to reduce neuropathic pain

Two new Manchester research centres aim at improving lives of people with arthritis

Tips to prevent sunburn and reduce risk of skin cancer

UNF Professor discovers 2 Lyme disease bacterial species that infect human patients

Infosys wins 2014 Simulating Reality contest for innovation in osteoporosis diagnosis

Medicare roundup: Alabama pain clinic spending 'hotspot'; quality improvement program scrutinized

Bullied children may experience long term health problems

Delayed care for Veterans is a hot topic on Sunday news shows, in headlines

Neuropathic pain features common in knee OA

PhotoMedex revenues decrease 12% to $50.1 million in first quarter 2014

NPS MedicineWise welcomes ABC’s decision to take down Catalyst program on statins, heart disease

Aratana initiates pivotal field effectiveness study for AT-001

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Pain News and Research

Latest Pain News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in